Kumar Chaudhary Harish, Singh Priyanka, Niveria Karishma, Yadav Monika, Malik Amita, Kamra Verma Anita
Department of Chemistry, Dyal Singh College, University of Delhi, 110003, New Delhi, India.
Nanobiotech Lab, Department of Zoology, Kirori Mal College, University of Delhi, Delhi 110007, India.
Int J Pharm. 2024 Sep 5;662:124452. doi: 10.1016/j.ijpharm.2024.124452. Epub 2024 Jul 10.
Insulin is commonly administered to diabetic patients subcutaneously and has shown poor patient compliance. Due to this, research has been carried out extensively to find molecules that could deliver insulin orally. In this context, a new type of pH-responsive hydrogel, composed of microcrystalline cellulose and methacrylic acid-based hydrogels, has been developed and studied for the oral delivery of insulin. These hydrogels were prepared by free radical polymerization using potassium persulphate as initiator and N, N'-methylenebisacrylamide as a cross-linker. These pH-sensitive hydrogels showed swelling in distilled water as high as 5800 %. The hydrogels were investigated for swelling in saline and glucose solutions, and pH sensitivity was confirmed by swelling in solutions of different pH. The morphological shape was established by SEM, and the structure was analyzed by FTIR. Thermal degradation was investigated by TGA. In vitro release studies have confirmed pH sensitivity, showing lower insulin release at pH 1.2 than at pH 6.8. The encapsulation efficiency was determined to be 56.00 ± 0.04 %. It was further validated by in-vivo investigations for which insulin was loaded into hydrogels and administered orally to healthy and diabetic Wistar rats at 40 IU/kg, showing maximum hypoglycemic effect at 6 h, which was sustained for 24 h. In the stomach's acidic environment, the gels remained unaffected due to the formation of intermolecular polymer complexes. Insulin remained in the gel and was protected from proteolytic degradation. Thus, pH-responsive methacrylic acid-based hydrogels are promising for biomedical applications, especially oral drug delivery.
胰岛素通常皮下注射给糖尿病患者,且患者依从性较差。因此,人们广泛开展研究以寻找能够口服递送胰岛素的分子。在此背景下,一种新型的pH响应性水凝胶已被开发并研究用于胰岛素的口服递送,该水凝胶由微晶纤维素和甲基丙烯酸基水凝胶组成。这些水凝胶通过自由基聚合制备,使用过硫酸钾作为引发剂,N,N'-亚甲基双丙烯酰胺作为交联剂。这些pH敏感水凝胶在蒸馏水中的溶胀率高达5800%。研究了水凝胶在盐水和葡萄糖溶液中的溶胀情况,并通过在不同pH溶液中的溶胀证实了pH敏感性。通过扫描电子显微镜(SEM)确定形态形状,通过傅里叶变换红外光谱(FTIR)分析结构。通过热重分析(TGA)研究热降解。体外释放研究证实了pH敏感性,显示在pH 1.2时胰岛素释放低于pH 6.8时。包封效率测定为56.00±0.04%。通过体内研究进一步验证,将胰岛素负载到水凝胶中并以40 IU/kg的剂量口服给予健康和糖尿病Wistar大鼠,在6小时时显示出最大降血糖作用,并持续24小时。在胃的酸性环境中,由于分子间聚合物复合物的形成,凝胶保持不受影响。胰岛素保留在凝胶中并受到保护免受蛋白水解降解。因此,基于甲基丙烯酸的pH响应性水凝胶在生物医学应用中,特别是口服药物递送方面具有前景。